39cef9df 868d 4963 B0a7 7f146275442f 01
Chemical structure diagram of Divalproex Sodium showing its molecular components and repeating unit.*
Divalproex Sodium Tablet, Delayed Release
Product Images NDC 50090-2007
7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-2007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
39cef9df 868d 4963 B0a7 7f146275442f 02
A bar graph comparing percentage values for placebo (PBO) and Divalproex Sodium (DVPX) across two studies labeled Study 1 and Study 2, measured in years (YRS) and months (MRS), respectively. The graph shows higher percentages for DVPX in both studies, with values approximately 60% and 58%, compared to placebo values of 26% and 29%.*
39cef9df 868d 4963 B0a7 7f146275442f 03
A cumulative proportion of responders plot showing percent reduction in CPS rate on the vertical axis and percent of patients on the horizontal axis, comparing the effects of Divalproex Sodium (solid line) versus Placebo (dashed line). The chart illustrates improvement and worsening relative to no change.*
39cef9df 868d 4963 B0a7 7f146275442f 04
A line graph showing percentage reduction in CPS rate versus percentage of patients comparing high dose and low dose treatments. The x-axis represents percentage of patients, and the y-axis indicates percentage reduction in CPS rate, with improvement and worsening directions marked.*
39cef9df 868d 4963 B0a7 7f146275442f 05
A bar chart comparing two studies showing the effects of Placebo and Divalproex Sodium. Each study presents two bars: one for Placebo and one for Divalproex Sodium, with differing heights indicating measured outcomes for each treatment group.*
39cef9df 868d 4963 B0a7 7f146275442f 06
Label Image (Lbl500902007)
Divalproex Sodium 250 mg delayed release tablets packaging label from A-S Medication Solutions. The label shows the product name, strength, dosage form, and storage instructions to store at 68 to 77 degrees Fahrenheit. The package contains 30 delayed release tablets and includes a QR code and barcode for product identification.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
